Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Immunology and Immunotherapy

We are delighted to share some highly viewed papers on cancer immunology and immunotherapy that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“Dendritic Cells in Cancer Immunology and Immunotherapy”
by Laura Hato, Angel Vizcay, Iñaki Eguren, José L. Pérez-Gracia, Javier Rodríguez, Jaime Gállego Pérez-Larraya, Pablo Sarobe, Susana Inogés, Ascensión López Díaz de Cerio and Marta Santisteban
Cancers 2024, 16(5), 981; https://doi.org/10.3390/cancers16050981
Available online: https://www.mdpi.com/2072-6694/16/5/981

“Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives”
by Ilaria Salvato and Antonio Marchini
Cancers 2024, 16(7), 1276; https://doi.org/10.3390/cancers16071276
Available online: https://www.mdpi.com/2072-6694/16/7/1276

“Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings”
by Daniel Park, Won Jin Jeon, Chieh Yang and Dani Ran Castillo
Cancers 2024, 16(2), 318; https://doi.org/10.3390/cancers16020318
Available online: https://www.mdpi.com/2072-6694/16/2/318

“The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review”
by Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, Marina Cipullo, Mario Romeo, Giovanna Palladino, Patrizia Iodice, Alessandro Federico and Teresa Troiani
Cancers 2024, 16(3), 611; https://doi.org/10.3390/cancers16030611
Available online: https://www.mdpi.com/2072-6694/16/3/611

“Triple Negative Breast Cancer: Molecular Subtype-Specific Immune Landscapes with Therapeutic Implications”
by Antonia Syrnioti, Stamatios Petousis, Lisa A. Newman, Chrysoula Margioula-Siarkou, Theodora Papamitsou, Konstantinos Dinas and Triantafyllia Koletsa
Cancers 2024, 16(11), 2094; https://doi.org/10.3390/cancers16112094
Available online: https://www.mdpi.com/2072-6694/16/11/2094

“Preclinical Evaluation of Novel Folate Receptor 1-Directed CAR T Cells for Ovarian Cancer”
by Julie Daigre, Manuel Martinez-Osuna, Maria Bethke, Larissa Steiner, Vera Dittmer, Katrin Krischer, Cathrin Bleilevens, Janina Brauner, Jens Kopatz, Matthias David Grundmann et al.
Cancers 2024, 16(2), 333; https://doi.org/10.3390/cancers16020333
Available online: https://www.mdpi.com/2072-6694/16/2/333

Special Issues:

“Oncolytic Viruses as an Emerging Aspect of Immune Oncology”
Guest Editor: Dr. Jennifer Altomonte
Submission deadline: 31 March 2025

“Immunotherapy with Checkpoint Inhibitors for Non-small Cell Lung Cancer”
Guest Editors: Dr. Alessandro Inno and Dr. Diego Signorelli
Submission deadline: 31 March 2025

“Evidence from the Real World Provides New Insights into the Evolving Landscape of Cancer Immunotherapy”
Guest Editors: Dr. Fabrizio Nelli, Dr. Carlo Signorelli, and Dr. Enzo Ruggeri
Submission deadline: 30 April 2025

“How to Properly Diagnose and Treat Immune-Related Adverse Events during Immunotherapy in Patients with Cancer: Discussion between Specialists”
Guest Editors: Dr. Angioletta Lasagna and Dr. Paolo Sacchi
Submission deadline: 30 April 2025

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office